Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined pain medication and exercise therapy for severe knee osteoarthritis pain
NL-OMON38793Active, not recruiting
- Sponsor
- Reade
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetaminophen, meloxicam and corticosteroids in knee osteoarthritis (OA), sponsored by Reade. Primary endpoints: Feasibility: participation in the STABILO exercise therapy program and Activity limitations: WOMAC physical function subscale. Started Jun 2013; status: active, not recruiting.
02
Drugs
acetaminophenmeloxicamcorticosteroids
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON38793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38793.